Enwave Corporation Stock
Price
Target price
?
?
-6.430%
-0.009
-6.430%
-
09:31 / Stuttgart Stock Exchange
WKN: A0JMA0 / Name: EnWave / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Enwave Corporation Stock
Heavy losses for Enwave Corporation today as the stock fell by -€0.009 (-6.430%).
Pros and Cons of Enwave Corporation in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -6.430% | -9.028% | -15.484% | -44.492% | -44.492% | -45.417% | -81.856% |
| Aurinia Pharmaceuticals Inc. | 1.540% | 3.575% | 6.966% | 98.278% | 4.306% | 59.659% | 38.084% |
| Spectral Medical Inc | 0.600% | -1.190% | -3.488% | 53.704% | 4.403% | 409.202% | 173.026% |
| Xenon Pharmaceuticals Inc. | - | 4.036% | -0.855% | 63.380% | 22.105% | 24.064% | - |
News
EnWave Reports 2026 First Quarter Consolidated Interim Financial Results
Vancouver, B.C., February 20th, 2026. EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the first
EnWave Signs Royalty-Bearing License with Bowen Gumlu Grower’s Association of Australia
Vancouver, B.C., February 2nd, 2026, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a royalty-bearing commercial license